Phase Ib/IIa study of iberdomide, in combination with dexamethasone, in patients with RRMM

Iberdomide in combination with dexamethasone and daratumumab, bortezomib, or carfilzomib in RRMM...Подробнее

Safety and efficacy of iberdomide + dexamethasone in patients with triple-class refractory myelomaПодробнее

$Safety and efficacy of iberdomide + dexamethasone in patients with triple-class refractory myeloma$

Iberdomide in Combination with DEX in pts with RRMM: Results from the CC-220-MM-001 TrialПодробнее

Iberdomide with dexamethasone for R/R multiple myelomaПодробнее

Results of Iberdomide in Combination with Dex and Daratumumab or Bortezomib in Patients with RRMMПодробнее

First clinical study of iberdomide, a CELMoD, in pts with relapsed/refractory multiple myelomaПодробнее

$First clinical study of iberdomide, a CELMoD, in pts with relapsed/refractory multiple myeloma$

Iberdomide in combination with dexamethasone for multiple myelomaПодробнее

A Phase Ib/II trial of sonrotoclax plus dexamethasone in patients with R/R MM harboring t(11;14)Подробнее

Iberdomide plus dexamethasone for heavily pretreated multiple myelomaПодробнее

Phase IB/II Study of Nivolumab in Combination with Azacytidine ...Подробнее

Phase Ib trial of entinostat in combination with pembrolizumab in R/R MDS or AMLПодробнее

Update on iberdomide treatment combinations in R/R myelomaПодробнее

CC-220-MM-001: IberDd, IberVd and IbrKd for R/R myelomaПодробнее

ASH 2014: Phase Ib study of daratumumab in combination with backbone regimens in myelomaПодробнее

Iberdomide + dexamethasone in R/R multiple myelomaПодробнее

Interim Phase 1b Study Results on Isatuximab and Pd Subcutaneous Administration in RRMM PatientsПодробнее

Iberdomide-based regimens in R/R multiple myelomaПодробнее

ASH 2014: Phase Ib study of daratumumab in combination with backbone regimens in myelomaПодробнее

Iberdomide with cyclophosphamide and dexamethasone in RRMM: first results from the ICON studyПодробнее